FIELD: medicine.
SUBSTANCE: invention refers to ophthalmology and aims at treatment of various conjunctival and corneal diseases involving damaged epithelium and formation of erosions and persistent ulcerations of trophic genesis. A reparative ophthalmic medicinal composition contains ethadene, taurine, nipagin, nipasol, methyl cellulose and purified water in a certain ratio (wt %).
EFFECT: invention provides a high reparative effect on tissues of the damaged cornea and improves composition tolerance by eye tissues with ensuring their comfort.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
EYE DROPS FOR TREATMENT OF DYSTROPHIC DISEASES AND TRAUMAS OF EYES | 2009 |
|
RU2414218C1 |
DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
OPHTHALMIC OINTMENT | 2007 |
|
RU2331408C1 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
EYE DROPS | 2012 |
|
RU2504372C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
Authors
Dates
2010-10-27—Published
2009-01-21—Filed